First day of public trading for £9.7m turnover health group
One Health Group, a provider of NHS-funded medical procedures, has confirmed its first day of dealings and admission of its ordinary shares to trading on the Apex segment of the AQSE Growth Market today.
The Sheffield-headquartered company has undertaken a placing and subscription which have raised, in aggregate, gross proceeds of £1,555,000, at a price per share of 150 pence.
On admission, the company will have 10,033,333 ordinary shares in issue, which implies a market capitalisation of the company of £15.05m, at the Issue Price.
Derek Bickerstaff, chairman of One Health, said: “We are pleased to become a publicly traded company by joining the AQSE Growth Market.
“One Health has currently achieved, and continues to achieve, revenue growth through the use of facilities within existing private hospitals and excess capacity offered by NHS facilities and the growing awareness of its services among medical practitioners and patients in our areas of operation.”
Adam Binns, chief executive officer, added: “We are also targeting additional surgeons that are looking to acquire AQP status and/or increase their own potential through use of the incremental infrastructure offered by the company.
“This includes provision of medical procedures through surgical hubs which is in line with Government policy and is strongly supported by the NHS and the Royal College of Surgeons.“
The business focuses on four specialties – Orthopaedics, Spinal Surgery, General Surgery and Gynaecology.
One Health achieved revenues of £9.7m in the six months to 30 September 2022.
Oberon Capital acted as the company’s AQSE corporate adviser and broker in relation to the admission and the placing and subscription, and is acting as the company’s AQSE corporate adviser and broker from admission.
